What did @coachdarianbates actually say?
The creator opened with aggressive bodybuilding-culture framing before pivoting to cite actual research. His core recommendation: start at 200mg of testosterone enanthate per week, increase in 50mg increments, and consider 300-600mg for bigger gains. He referenced a real dose-response study comparing 25, 50, 125, 300, and 600mg weekly doses over 12 weeks. He also argued that 100-200mg sits at "TRT levels," and that an aromatase inhibitor isn't necessarily needed at lower doses. The tone was performatively aggressive, but the second half of the video was more grounded than most steroid content on TikTok. That doesn't make it safe advice. Recommending supraphysiologic testosterone doses to an unscreened general audience, without labs, without a prescriber, and framed as a performance cycle, is a different animal than legitimate hormone optimization.
Does the science back this up?
The study he cited is real, and the numbers he pulled are largely accurate. Yes, the research shows a dose-response relationship. But context matters enormously here, and he left out most of it.
The study in question is Bhasin et al. (2001, New England Journal of Medicine), which suppressed endogenous testosterone production in 61 healthy men using a GnRH analog, then administered graded doses. The fat-free mass gains he quoted, roughly 3.4kg at 125mg and 7.9kg at 600mg, are consistent with the published data. So he read the study. Credit where it's due.
What he didn't mention: participants were eugonadal men whose natural production was chemically shut off first. The design was to isolate exogenous dose effects, not to model what happens when you stack supraphysiologic doses on top of existing testosterone. The cardiovascular, hematologic, and psychiatric risk data from that study, and from the broader literature, didn't make the cut in his video.
A 2023 meta-analysis by Lincoff et al. in the New England Journal of Medicine also found increased rates of nonfatal arrhythmia in testosterone-treated men, adding to a body of evidence that high-dose use carries real cardiac risk, particularly over repeated cycles.
What did they get wrong (or right)?
He got the study citation directionally right. The dose-response relationship between testosterone and lean mass gain is well-established, and his numbers track with Bhasin 2001. Calling 100-200mg a week "TRT levels" is also roughly consistent with clinical practice, though actual therapeutic dosing is individualized based on labs, not a blanket range.
Where he went wrong, and this matters, is in framing 300-600mg weekly as a reasonable starting point for a general audience without any clinical screening. At 600mg per week, you are well into supraphysiologic territory. Risks at that range include erythrocytosis, elevated hematocrit, dyslipidemia, suppression of the HPG axis, potential cardiac remodeling with long-term use, and mood instability. None of that appeared in the video.
His claim that you can skip an aromatase inhibitor at lower doses deserves nuance. Aromatization varies significantly between individuals based on body composition, genetics, and baseline estradiol. Blanket "you might not need an AI" advice to an anonymous audience is not the same as a clinician reviewing someone's labs and making that call.
The opening section, where he mocks beginners as "little girls" for starting at 250mg, is not just juvenile. It actively pushes people toward higher doses faster, which is the opposite of the harm-reduction framing he eventually adopts.
What should you actually know?
Testosterone at supraphysiologic doses is not a supplement decision. It is a medical intervention with real downstream consequences. The dose-response curve for muscle gain is real, but so is the dose-response curve for adverse effects.
If you are experiencing symptoms of low testosterone, including fatigue, low libido, cognitive fog, or mood changes, the appropriate starting point is bloodwork, not a TikTok cycle protocol. Legitimate TRT is prescribed based on total testosterone, free testosterone, LH, FSH, hematocrit, PSA, and other markers. It is managed over time with follow-up labs.
Performance-enhancement cycles at 300-600mg weekly are not TRT. They are pharmacological interventions with meaningful risk profiles, especially for younger men whose HPG axes have not fully matured, or anyone with undiagnosed cardiovascular risk factors.
The Bhasin 2001 study is worth reading in full, not just the lean mass numbers. The researchers also documented dose-dependent increases in prostate size and hematocrit, effects that compound with repeated cycling. That context didn't make the TikTok cut.
- Do not start any testosterone protocol without baseline bloodwork and a licensed prescriber reviewing your results.
- Aromatase inhibitor use should be guided by estradiol labs, not preemptive dosing or skipped based on a general recommendation.
- Post-cycle recovery, fertility impact, and HPG suppression are real considerations that this video did not address.